Viewing Study NCT07037433


Ignite Creation Date: 2025-12-25 @ 2:58 AM
Ignite Modification Date: 2025-12-30 @ 4:33 PM
Study NCT ID: NCT07037433
Status: RECRUITING
Last Update Posted: 2025-11-13
First Post: 2025-06-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module